Skip to main content
Clinical Trials/NCT06540287
NCT06540287
Recruiting
Not Applicable

An Observational Study of Aging Biomarkers in Older Elite Athletes Compared to Non-exercising Healthy Older Adults.

Buck Institute for Research on Aging1 site in 1 country80 target enrollmentSeptember 19, 2024
ConditionsAging

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Aging
Sponsor
Buck Institute for Research on Aging
Enrollment
80
Locations
1
Primary Endpoint
Muscle cellular aging - single cell transcriptomics
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This study is to investigate characteristics of muscle, blood, and urine samples from older adults (ages 65-80) who are either sedentary or athletes performing at an elite level for their age. This observational study will include bio-specimen collection, as well as physical and cognitive function testing and body composition.

Detailed Description

The study will enroll a total of 80 subjects-20 of each gender for each cohort. Participation in the study involves 3 visits that must take place within 12 weeks. Optional l follow up visits may be completed at 12- and 24- months after completion of the main study. The first visit is a screening and enrollment visit. At this visit, informed consent will be obtained and a detailed medical history, screening blood sample collected, and physical assessment will be performed (including, but not limited to vital signs, resting ECG, body composition). Additionally, an exercise history interview will be performed to assess for cohort eligibility. Participants will be familiarized with testing equipment during the screening visit and will perform the Astrand-Rhyming submaximal bicycle test. A short physical function testing battery will be performed, including the short physical performance battery, 6 minute walk test, grip strength, 1 rep max leg press, and leg press fatigue testing. The second visit will include maximal exercise testing, quality of life assessment, and cognitive function testing. Participants will be allocated into their cohort at this visit. The third visit will include thigh muscle sample collection via needle biopsy and blood sample collection.

Registry
clinicaltrials.gov
Start Date
September 19, 2024
End Date
May 2027
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Muscle cellular aging - single cell transcriptomics

Time Frame: Day 2

Differences between athletes and sedentary in muscle single cell transcriptomic between OEA and HOA groups

Muscle cellular aging - spatial transcriptomics

Time Frame: Day 2

Differences between athletes and sedentary in muscle spatial transcriptomic between OEA and HOA groups

Secondary Outcomes

  • Physical function - 6 minute walk test(Day 1)
  • Blood cell immune function(Day 2)
  • Physical function - leg press fatigue(Day 1)
  • Differences between concentration of metabolites in the muscle(Day 2)
  • Differences between concentration of proteins in the muscle(Day 2)
  • Differences between function of muscle mitochondria(Day 2)
  • Blood cell gene expression(Day 2)
  • Physical function - grip strength(Day 1)
  • Physical function - short physical performance battery(Day 1)
  • Physical function - leg strength(Day 1)
  • Blood metabolites(Day 2)
  • Blood proteins(Day 2)
  • Urine metabolites(Day 2)
  • Physical function - VO2 max(Day 1)

Study Sites (1)

Loading locations...

Similar Trials